New Key Statistics Module, Z-Score and F-Score
DHA:BXPHARMA Key Ratios
Market Cap BDT M | 36,135.08 |
Enterprise Value BDT M | 43,725.39 |
P/E(ttm) | 6.17 |
PE Ratio without NRI | 6.17 |
Forward PE Ratio | 6.02 |
Price/Book | 0.74 |
Price/Sales | 0.81 |
Price/Free Cash Flow | 6.82 |
Price/Owner Earnings | 9.66 |
Payout Ratio % | 0.26 |
Revenue (TTM) BDT M | 44,946.00 |
EPS (TTM) BDT | 13.35 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | 16.20 |
5-y EBITDA Growth Rate % | 16.40 |
y-y EBITDA Growth Rate % | 17.40 |
EV-to-EBIT | 4.98 |
EV-to-EBITDA | 4.98 |
PEG | 0.38 |
Shares Outstanding M | 446.11 |
Net Margin (%) | 13.25 |
Operating Margin % | 19.66 |
Pre-tax Margin (%) | 17.06 |
Quick Ratio | 0.91 |
Current Ratio | 2.43 |
ROA % (ttm) | 8.48 |
ROE % (ttm) | 12.60 |
ROIC % (ttm) | 10.75 |
Dividend Yield % | 4.94 |
Altman Z-Score | 3.28 |
DHA:BXPHARMA Number of Guru Trades
DHA:BXPHARMA Volume of Guru Trades
Gurus Latest Trades with DHA:BXPHARMA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
DHA:BXPHARMA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data